PPH

VanEck Vectors Pharmaceutical ETF

Up$57.12
+$0.38
(+0.67%)
As of 2:15:13 PM EDT | 10/16/19  |  Market Open

PPH Trading Data

Open

$56.99

Low Price

$56.99

High Price

$57.42

Previous Last Price

$56.74

Bid Size

$56.96 X 300

Ask Size

$57 X 1200

PPH Portfolio Data

AUM

$178,501,700

Shares

3,188

PE Ratio

25.57

Price / Book Ratio

2.59

Expense Ratio

0.36

Net Asset Value

$55.99

Volume

Volume

18,176

Avg. Volume (YDT)

53,732

Dollar Volume

$991,350

Weekly Avg. Volume

174,235

Monthly Avg. Volume

73,659

Quarterly Avg. Volume

64,152

PPH Fund Description

The VanEck Vectors Pharmaceutical ETF seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals. Expenses for PPH are capped contractually at 0.35% until at least February 1, 2018. Cap excludes certain expenses, such as interest.

PPH Chart

PPH Summary

Fund Family

Van Eck Associates

Tracks This Index

VanEck Vectors Pharmaceutical ETF

Inception Date

2011-12-21

Asset Class

Equity

Asset Class Size

Healthcare

PPH Classification

Region (General)

Global

Region (Specific)

Sector

Health Care

Equity Index

Leveraged Family

PPH Holdings

Top 10 Holdings

Abbvie Inc (ABBV)
5.49%
Glaxosmithkline Plc (GSK)
5.35%
Sanofi (SNY)
5.34%
Novo Nordisk A/S (NVO)
5.3%
Merck & Co Inc (MRK)
5.28%
Asazeneca Plc (AZN)
5.26%
Johnson & Johnson (JNJ)
5.16%
Pfizer Inc (PFE)
5.02%
Novartis Ag (NVS)
5%
Eli Lilly & Co (LLY)
5%

Total PPH Holdings

Total Holdings: 26

Abbvie Inc (ABBV)
5.49%
Glaxosmithkline Plc (GSK)
5.35%
Sanofi (SNY)
5.34%
Novo Nordisk A/S (NVO)
5.3%
Merck & Co Inc (MRK)
5.28%
Asazeneca Plc (AZN)
5.26%
Johnson & Johnson (JNJ)
5.16%
Pfizer Inc (PFE)
5.02%
Novartis Ag (NVS)
5%
Eli Lilly & Co (LLY)
5%
Zoetis Inc (ZTS)
4.88%
Bristol-Myers Squibb Co (BMY)
4.88%
Takeda Pharmaceutical Co Ltd (TAK)
4.62%
Amerisourcebergen Corp (ABC)
4.33%
Mckesson Corp (MCK)
4.2%
Mylan Nv (MYL)
3.79%
Bausch Health Cos Inc (BHC)
3.49%
Teva Pharmaceutical Indusies Ltd (TEVA)
3.27%
Elanco Animal Health Inc (ELAN)
3.25%
Jazz Pharmaceuticals Plc (JAZZ)
2.79%
Amarin Corp Plc (AMRN)
2.58%
Perrigo Co Plc (PRGO)
2.01%
Catalent Inc (CTLT)
1.82%
Gw Pharmaceuticals Plc (GWPH)
1.5%
Patterson Cos Inc (PDCO)
0.48%
Market Vectors Pharmaceutical ETF (PPH)
0%

PPH Technicals

Alpha

-10.1

Beta

0.94

Leverage

Long

Standard Deviation

2.48

PPH Dividends

Dividend Date

2019-10-01

Latest Dividend

0.292

Annual Dividend

1.17

Annual Dividend Rate

1.17

Annual Dividend Yield

2.08

PPH Performance

YTD Return

4.25%

1 Year Return

-9.17%

3 Year Return

3%

5 Year Return

-8.9%

10 Year Return

85.82%

PPH Related Articles

© 2019 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.

Fundamental company data provided by Morningstar and Zacks Investment Research. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.